Frequent MED12 mutations in phyllodes tumours of the breast

M. Yoshida, S. Sekine, R. Ogawa, H. Yoshida, A. Maeshima, Y. Kanai, T. Kinoshita, A. Ochiai

研究成果: Article査読

67 被引用数 (Scopus)


Background:Phyllodes tumours are rare fibroepithelial tumours of the breast, that include benign, borderline, and malignant lesions. Although the molecular basis of phyllodes tumours largely remains unknown, a recent exome study identified MED12 mutations as a sole recurrent genetic alteration in fibroadenoma, a common benign fibroepithelial tumour that shares some histological features with the phyllodes tumour.Methods:Forty-six phyllodes tumours and 58 fibroadenomas of the breast were analysed for MED12 mutations by using Sanger sequencing.Results:MED12 mutations were identified in 37 out of the 46 phyllodes tumours (80%). The prevalence of MED12 mutations was similar among benign (15/18, 83%), borderline (12/15, 80%), and malignant tumours (10/13, 77%). MED12 mutations were also identified in 36 of the 58 fibroadenomas (62%). The mutations were frequent among intracanalicular-type (24/32, 75%) and complex-type lesions (4/6, 67%), but were significantly less common among the pericanalicular-type lesions (8/20, 40%). A microdissection-based analysis showed that MED12 mutations were confined to the stromal components in both phyllodes tumours and fibroadenomas.Conclusions:MED12 mutations were frequent among the phyllodes tumours of the breast, regardless of the tumour grade. Phyllodes tumours and fibroadenomas share, at least in part, a common genetic background.

ジャーナルBritish Journal of Cancer
出版ステータスPublished - 2015 5月 12

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究


「Frequent MED12 mutations in phyllodes tumours of the breast」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。